Skip to main content

. 1989 Jul;52(7):917–918. doi: 10.1136/jnnp.52.7.917

Effect of tropatepine, an anticholinergic drug, on regional cerebral blood flow in patients with Parkinson's disease.

P Celsis, J L Montastruc, O Rascol, J M Senard, J P Marc-Vergnes, A Rascol

PMCID: PMC1031949 PMID: 2769291

917

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Celsis P., Rascol O., Demonet J. F., Agniel A., Montastruc J. L., Marc-Vergnes J. P., Rascol A. Effet de la bromocriptine sur le débit sanguin cérébral dans la maladie de Parkinson. Rev Neurol (Paris) 1988;144(5):367–371. [PubMed] [Google Scholar]
Collewijn H., Apkarian P., Spekreijse H. The oculomotor behaviour of human albinos. Brain. 1985 Mar;108(Pt 1):1–28. doi: 10.1093/brain/108.1.1. [DOI] [PubMed] [Google Scholar]
Honer W. G., Prohovnik I., Smith G., Lucas L. R. Scopolamine reduces frontal cortex perfusion. J Cereb Blood Flow Metab. 1988 Oct;8(5):635–641. doi: 10.1038/jcbfm.1988.110. [DOI] [PubMed] [Google Scholar]
Marc-Vergnes J. P., Celsis P., Montastruc J. L., Demonet J. F., Agniel A., Rascol O., Viallard G., Doyon B., Rascol A. Hémodynamique cérébrale et pharmacologie clinique dans la maladie de Parkinson. Therapie. 1988 Mar-Apr;43(2):83–88. [PubMed] [Google Scholar]
Scremin O. U., Sonnenschein R. R., Rubinstein E. H. Cholinergic cerebral vasodilatation in the rabbit: absence of concomitant metabolic activation. J Cereb Blood Flow Metab. 1982;2(2):241–247. doi: 10.1038/jcbfm.1982.24. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES